PSY27 Cost Effectiveness of Treatment With Etanercept or Ustekinumab for Moderate to Severe Psoriasis
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.561
https://www.valueinhealthjournal.com/article/S1098-3015(12)00626-2/fulltext
Title :
PSY27 Cost Effectiveness of Treatment With Etanercept or Ustekinumab for Moderate to Severe Psoriasis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00626-2&doi=10.1016/j.jval.2012.03.561
First page :
A103
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
28